147 related articles for article (PubMed ID: 4281938)
41. [A study on the participation of protein kinase C in the blood coagulation].
Abe K
Hokkaido Igaku Zasshi; 1993 May; 68(3):368-76. PubMed ID: 8319935
[TBL] [Abstract][Full Text] [Related]
42. [Action of vitreous body in the blood coagulation].
Regnault F; Larrieu MJ
Pathol Biol (Paris); 1969 Jan; 17(1):31-7. PubMed ID: 4895968
[No Abstract] [Full Text] [Related]
43. Renal vascular resistance changes following thrombin-induced intravascular coagulation: role of platelet and fibrin emboli.
Hoie J
Acta Chir Scand; 1975; 141(3):167-72. PubMed ID: 1166740
[TBL] [Abstract][Full Text] [Related]
44. [Hemostatic disorders in the treatment of leukoblastosis with L-asparaginase (crasnitin)].
Genova V
Vutr Boles; 1973; 12(2):43-9. PubMed ID: 4268271
[No Abstract] [Full Text] [Related]
45. Thrombin interaction with human platelets. Potentiation of thrombin-induced aggregation and release by inactivated thrombin.
Phillips DR
Thromb Diath Haemorrh; 1974 Sep; 32(1):207-15. PubMed ID: 4454040
[TBL] [Abstract][Full Text] [Related]
46. [Participation of sialic acid residue in the fibrinogen-fibrin conversion by thrombin].
Akihama S; Matsuda Y; Fukase T; Yamanaka A; Okude M
Yakugaku Zasshi; 1995 Jul; 115(7):537-42. PubMed ID: 7562401
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of human platelet aggregation by plasmin digests of human and bovine fibrinogen preparations: role of contaminating factor VIII-related material.
Culasso DE; Donati MB; de Gaetano G; Vermylen J; Verstraete M
Blood; 1974 Aug; 44(2):169-75. PubMed ID: 4277539
[No Abstract] [Full Text] [Related]
48. Hemorrhagic syndrome in dogs induced by intravenous thrombin.
Girolami A; Cliffton EE; Agostino D
Thromb Diath Haemorrh; 1966 Jul; 16(1):243-56. PubMed ID: 5989044
[No Abstract] [Full Text] [Related]
49. [Fibrinogen derivatives appearing in calf plasma after the action of thrombin and endotoxin].
Benabid Y; Laurent M; Concord E; Suscillon M
Pathol Biol (Paris); 1973 Nov; 21():Suppl:24-30. PubMed ID: 4587012
[No Abstract] [Full Text] [Related]
50. Alkaloids of tobacco and blood coagulation: effect of nicotine on thrombin and fibrinogen.
Singh JM; Singh MD
Clin Toxicol; 1975; 8(1):43-52. PubMed ID: 1137933
[TBL] [Abstract][Full Text] [Related]
51. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution.
Haas T; Fries D; Velik-Salchner C; Reif C; Klingler A; Innerhofer P
Anesth Analg; 2008 May; 106(5):1360-5, table of contents. PubMed ID: 18420845
[TBL] [Abstract][Full Text] [Related]
52. [The fibrinolytic activity in Seegers' cattle prothrombin preparations. A contribution to the problem of the activation of cattle prothrombin by plasmin].
Andrassy K; Egbring R; Egli H
Thromb Diath Haemorrh; 1969 Nov; 22(2):377-90. PubMed ID: 4245334
[No Abstract] [Full Text] [Related]
53. [Effect of thrombolytic agents on platelets and blood coagulation system].
Suehiro A
Rinsho Byori; 1997 Oct; 45(10):951-6. PubMed ID: 9369072
[TBL] [Abstract][Full Text] [Related]
54. Studies on the thrombin clotting time. I. The influence of fibrinogen degradation products.
Arnesen H; Godal HC
Scand J Haematol; 1973; 10(3):232-40. PubMed ID: 4797626
[No Abstract] [Full Text] [Related]
55. [The dynamics of the activity of various clotting and fibrinolytic factors in preserved blood in relation to duration of blood storage].
Kal'chenko II; Lys PV; Riabyĭ PA
Vestn Khir Im I I Grek; 1971 Oct; 107(10):122-6. PubMed ID: 5142224
[No Abstract] [Full Text] [Related]
56. Determination of the amount of thrombin generated in undiluted plasma during coagulation. Effect of platelets, thromboplastin, factor VIII and prothrombin complex.
Triantaphyllopoulos DC
Thromb Res; 1978 Dec; 13(6):915-29. PubMed ID: 155324
[No Abstract] [Full Text] [Related]
57. [Immunological and hemocoagulative characteristics of serums of rabbits immunized with prothrombin, fibrinolysin (plasmin), fibrinogen and thrombin. (Experimental immuno-coagulopathy)].
DE NICOLA P; ZANGAGLIA O; SOARDI F
Riv Emoter Immunoematol; 1959; 6():161-78. PubMed ID: 13814944
[No Abstract] [Full Text] [Related]
58. Phospholipid requirements in thrombin formation.
Zolton RP; Seegers WH
Thromb Res; 1974 Mar; 4(3):437-46. PubMed ID: 4364365
[No Abstract] [Full Text] [Related]
59. BLOOD COAGULATION: PRACTICAL SIGNIFICANCE OF RECENT ADVANCES IN KNOWLEDGE OF PROTHROMBIN.
SEEGERS WH
Tex State J Med; 1963 Nov; 59():1068-75. PubMed ID: 14084901
[No Abstract] [Full Text] [Related]
60. Preparation of degradation products of fibrinogen free of plasmin, and their effect on thrombin activity.
Chandra S; Triantaphyllopoulos DC
Can J Physiol Pharmacol; 1972 Jul; 50(7):655-61. PubMed ID: 4262076
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
